Morphological changes of regional lymph node in squamous cell carcinoma of the oral cavity

Journal of Oral Pathology and Medicine

Volumn 34, Issue 4, 2005, Pages 214-219

  Okura, Masaya ^a   Kagamiuchi, Hajime ^a   Tominaga, Gyo ^a   Iida, Seiji ^a   Fukuda, Yasuo ^b   Kogo, Mikihiko ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY DENTAL HOSPITAL   (Japan)

Author keywords

Germinal center; Head and neck cancer; Host immune response; Immunosuppression; Lymph node metastasis; Oral cavity cancer; Paracortical hyperplasia; Squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; IMMUNE RESPONSE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; GERMINAL CENTER; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 15944377906     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2005.00304.x     Document Type: Article

References (32)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64.
2. Shah JP, Medina JE, Shaha AR, Schantz SP, Marti JR. Cervical lymph node metastasis. Curr Probl Surg 1993; 30: 284-335.
3. Okura M. Lymph node metastasis. In: Pandalai SG, ed. Recent research developments in cancer. Vol. 4, Part 1. Trivandrum, India: Transworld Research Network, 2002; 331-7.
4. Cady B. Lymph node metastases. Indicators, but not governors of survival. Arch Surg 1984; 119: 1067-72.
5. Delilbasi CB, Okura M, Iida S, Kogo M. Investigation of CXCR4 in squamous cell carcinoma of the tongue. Oral Oncol 2004; 40: 154-7.
6. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-6.
7. Santin AD. Lymph node metastases: the importance of the microenvironment. Cancer 2000; 88: 175-9.
8. Di Giorgio A, Mingazzini P, Sammartino P, Canavese A, Arnone P, Scarpini M. Host defense and survival in patients with lung carcinoma. Cancer 2000; 89: 2038-45.
9. Amar A, Rapoport A, Rosas MP. Evaluation of lymph node reactivity in differentiated thyroid carcinoma. Sao Paulo Med J 1999; 117: 125-8.
10. Stankiewicz C. Prognostic significance of lymph node reactivity in patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 1994; 251: 418-22.
11. Ring AH, Sako K, Rao U, Razack MS, Reese P. Immunologic patterns of regional lymph nodes in squamous cell carcinoma of the floor of the mouth. Prognostic significance. Am J Surg 1985; 150: 461-5.
12. Pihl E, Malahy MA, Khankhanian N, Hersh EM, Mavligit GM. Immunomorphological features of prognostic significance in Dukes' Class B colorectal carcinoma. Cancer Res 1977; 37: 4145-9.
13. Di Giorgio A, Botti C, Mingazzini P, Canavese A, Arnone P. Gastric cancer: prognosis and lymph node reactivity. Eur J Surg 1995; 161: 575-80.
14. Gallo O, Boddi V, Bottai GV, Franchi A, Storchi OF. Prognostic significance of clinically false positive cervical lymph nodes in patients with laryngeal carcinoma. Cancer 1995; 75: 1077-83.
15. Patt BS, Close LG, Vuitch F. Prognostic significance of sinus histiocytosis in metastatic laryngeal cancer. Laryngoscope 1993; 103: 498-502.
16. Hunter RL, Ferguson DJ, Coppleson LW. Survival with mammary cancer related to the interaction of germinal center hyperplasia and sinus histiocytosis in axillary and internal mammary lymph nodes. Cancer 1975; 36: 528-39.
17. Cernea C, Montenegro F, Castro I, et al. Prognostic significance of lymph node reactivity in the control of pathologic negative node squamous cell carcinomas of the oral cavity. Am J Surg 1997; 174: 548-51.
18. Black MM, Freeman C, Mork T, Harvei S, Cutler SJ. Prognostic significance of microscopic structure of gastric carcinomas and their regional lymph nodes. Cancer 1971; 27: 703-11.
19. Check IJ, Cobb M, Hunter RL. The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast. Am J Pathol 1980; 98: 325-38.
20. Syrjanen KJ. Paracortical activity in the lymph nodes draining female breast carcinoma. Neoplasma 1979; 26: 95-102.
21. Cochran AJ, Pihl E, Wen DR, Hoon DS, Kone EL. Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studies. J Natl Cancer Inst 1987; 78: 399-405.
22. Okura M, Hiranuma T, Adachi T, et al. Induction chemotherapy is associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity: results from a single institution. Cancer 1998; 82: 804-15.
23. Sobin LH, Wittekind C. UICC International union against cancer 1997. TNM classification of malignant tumours, 5th edn. Tokyo, Japan: Kanehara & Co., Ltd, 1997.
24. Hoon DS, Korn EL, Cochran AJ. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans. Cancer Res 1987; 47: 1740-4.
25. Farzad Z, Cochran AJ, McBride WH, Gray JD, Wong V, Morton DJ. Lymphocyte subset alterations in nodes regional to human melanoma. Cancer Res 1990; 50: 3585-8.
26. de Gruijl TD, Bontkes HJ, Peccatori F, et al. Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes. Br J Cancer 1999; 79: 1127-32.
27. Shibuya TY, Nugyen N, McLaren CE, et al. Clinical significance of poor CD3 response in head and neck cancer. Clin Cancer Res 2002; 8: 745-51.
28. Gastman BR, Atarshi Y, Reichert TE, et al. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Cancer Res 1999; 59: 5356-64.
29. Gastman BR, Johnson DE, Whiteside TL, Rabinowich H. Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events. Blood 2000; 95: 2015-23.
30. Verastegui E, Morales R, Barrera JL, et al. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck. Clin Immunol 2002; 102: 37-47.
31. Shibuya TY, Wei WZ, Zormeier M, et al. Anti-CD3/ anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2000; 126: 473-9.
32. Meneses A, Verastegui E, Barrera JL, de la Garza J, Hadden JW. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2. Int Immunopharmacol 2003; 3: 1083-91.